Arkolith/Insider Trading/SER/Form 4

Moreadith Randall

Chief Scientific OfficerSerina Therapeutics, Inc. (SER) · full profile →Form 4 · filed Jan 14, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$16K
Net Open-Market Flow
-$16K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 14, 2026Option exercise(M)1K$0.06$651K
Jan 14, 2026Sell(S)1K$2.50$3K0
Jan 13, 2026Sell(S)5K$2.50$14K0
Jan 13, 2026Option exercise(M)5K$0.06$3255K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 14, 2026Option exercise(M)1K—$0333K
Jan 13, 2026Option exercise(M)5K—$0334K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001301120-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML